2023
IL-7R licenses a population of epigenetically poised memory CD8+ T cells with superior antitumor efficacy that are critical for melanoma memory
Micevic G, Daniels A, Flem-Karlsen K, Park K, Talty R, McGeary M, Mirza H, Blackburn H, Sefik E, Cheung J, Hornick N, Aizenbud L, Joshi N, Kluger H, Iwasaki A, Bosenberg M, Flavell R. IL-7R licenses a population of epigenetically poised memory CD8+ T cells with superior antitumor efficacy that are critical for melanoma memory. Proceedings Of The National Academy Of Sciences Of The United States Of America 2023, 120: e2304319120. PMID: 37459511, PMCID: PMC10372654, DOI: 10.1073/pnas.2304319120.Peer-Reviewed Original ResearchConceptsIL-7R expressionT cellsIL-7RAntitumor memorySuperior antitumor efficacyCell-based therapiesTumor-specific T cellsAntigen-specific T cellsAntitumor efficacyPowerful antitumor immune responseMarkers of exhaustionTumor-specific CD8Antitumor immune responseIndependent prognostic factorAntitumor immune memoryMemory T cellsMajor risk factorSuperior antitumor activityFunctional CD8Memory CD8Prognostic factorsSurgical resectionAdvanced melanomaLymph nodesNaive mice
2021
The role of ferroptosis in melanoma
Talty R, Bosenberg M. The role of ferroptosis in melanoma. Pigment Cell & Melanoma Research 2021, 35: 18-25. PMID: 34407291, DOI: 10.1111/pcmr.13009.Peer-Reviewed Original ResearchConceptsImmune checkpoint inhibitorsNovel therapeutic targetIron-dependent regulated cell deathContext of melanomaRole of ferroptosisDysregulation of ferroptosisForms of cancerCheckpoint inhibitorsAdvanced melanomaImmunotherapy regimensMelanoma patientsTargeted therapyTherapeutic targetSkin cancerMelanomaDeadliest formTherapyRegulated cell deathFerroptosisPatientsCancerCell deathCurrent literatureRegimensRelapse